664 related articles for article (PubMed ID: 8567978)
1. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
[TBL] [Abstract][Full Text] [Related]
2. Monomeric phospholamban overexpression in transgenic mouse hearts.
Chu G; Dorn GW; Luo W; Harrer JM; Kadambi VJ; Walsh RA; Kranias EG
Circ Res; 1997 Oct; 81(4):485-92. PubMed ID: 9314829
[TBL] [Abstract][Full Text] [Related]
3. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo.
Zhai J; Schmidt AG; Hoit BD; Kimura Y; MacLennan DH; Kranias EG
J Biol Chem; 2000 Apr; 275(14):10538-44. PubMed ID: 10744747
[TBL] [Abstract][Full Text] [Related]
4. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
Neumann J; Boknik P; DePaoli-Roach AA; Field LJ; Rockman HA; Kobayashi YM; Kelley JS; Jones LR
J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
[TBL] [Abstract][Full Text] [Related]
5. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure.
Haghighi K; Schmidt AG; Hoit BD; Brittsan AG; Yatani A; Lester JW; Zhai J; Kimura Y; Dorn GW; MacLennan DH; Kranias EG
J Biol Chem; 2001 Jun; 276(26):24145-52. PubMed ID: 11328820
[TBL] [Abstract][Full Text] [Related]
6. Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport.
Brittsan AG; Ginsburg KS; Chu G; Yatani A; Wolska BM; Schmidt AG; Asahi M; MacLennan DH; Bers DM; Kranias EG
Circ Res; 2003 Apr; 92(7):769-76. PubMed ID: 12637367
[TBL] [Abstract][Full Text] [Related]
7. Phospholamban overexpression in rabbit ventricular myocytes does not alter sarcoplasmic reticulum Ca transport.
Waggoner JR; Ginsburg KS; Mitton B; Haghighi K; Robbins J; Bers DM; Kranias EG
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H698-703. PubMed ID: 19112098
[TBL] [Abstract][Full Text] [Related]
8. The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility.
Zvaritch E; Backx PH; Jirik F; Kimura Y; de Leon S; Schmidt AG; Hoit BD; Lester JW; Kranias EG; MacLennan DH
J Biol Chem; 2000 May; 275(20):14985-91. PubMed ID: 10809743
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation.
He H; Giordano FJ; Hilal-Dandan R; Choi DJ; Rockman HA; McDonough PM; Bluhm WF; Meyer M; Sayen MR; Swanson E; Dillmann WH
J Clin Invest; 1997 Jul; 100(2):380-9. PubMed ID: 9218515
[TBL] [Abstract][Full Text] [Related]
10. Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to beta-adrenergic agonists.
Kirchhefer U; Jones LR; Begrow F; Boknik P; Hein L; Lohse MJ; Riemann B; Schmitz W; Stypmann J; Neumann J
Cardiovasc Res; 2004 Apr; 62(1):122-34. PubMed ID: 15023559
[TBL] [Abstract][Full Text] [Related]
11. Targeted inhibition of sarcoplasmic reticulum CaMKII activity results in alterations of Ca2+ homeostasis and cardiac contractility.
Ji Y; Zhao W; Li B; Desantiago J; Picht E; Kaetzel MA; Schultz Jel J; Kranias EG; Bers DM; Dedman JR
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H599-606. PubMed ID: 16143658
[TBL] [Abstract][Full Text] [Related]
12. Enhanced myocardial contractility and increased Ca2+ transport function in transgenic hearts expressing the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase.
Loukianov E; Ji Y; Grupp IL; Kirkpatrick DL; Baker DL; Loukianova T; Grupp G; Lytton J; Walsh RA; Periasamy M
Circ Res; 1998 Nov; 83(9):889-97. PubMed ID: 9797337
[TBL] [Abstract][Full Text] [Related]
13. Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice.
Asahi M; Otsu K; Nakayama H; Hikoso S; Takeda T; Gramolini AO; Trivieri MG; Oudit GY; Morita T; Kusakari Y; Hirano S; Hongo K; Hirotani S; Yamaguchi O; Peterson A; Backx PH; Kurihara S; Hori M; MacLennan DH
Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9199-204. PubMed ID: 15201433
[TBL] [Abstract][Full Text] [Related]
14. Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban.
Brittsan AG; Carr AN; Schmidt AG; Kranias EG
J Biol Chem; 2000 Apr; 275(16):12129-35. PubMed ID: 10766848
[TBL] [Abstract][Full Text] [Related]
15. Enhanced myocyte contractility and Ca2+ handling in a calcineurin transgenic model of heart failure.
Chu G; Carr AN; Young KB; Lester JW; Yatani A; Sanbe A; Colbert MC; Schwartz SM; Frank KF; Lampe PD; Robbins J; Molkentin JD; Kranias EG
Cardiovasc Res; 2002 Apr; 54(1):105-16. PubMed ID: 12062367
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts.
Kiss E; Brittsan AG; Edes I; Grupp IL; Grupp G; Kranias EG
Circ Res; 1998 Sep; 83(6):608-13. PubMed ID: 9742056
[TBL] [Abstract][Full Text] [Related]
17. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium.
Dash R; Frank KF; Carr AN; Moravec CS; Kranias EG
J Mol Cell Cardiol; 2001 Jul; 33(7):1345-53. PubMed ID: 11437540
[TBL] [Abstract][Full Text] [Related]
18. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.
Luo W; Grupp IL; Harrer J; Ponniah S; Grupp G; Duffy JJ; Doetschman T; Kranias EG
Circ Res; 1994 Sep; 75(3):401-9. PubMed ID: 8062415
[TBL] [Abstract][Full Text] [Related]
19. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.
Brittsan AG; Kiss E; Edes I; Grupp IL; Grupp G; Kranias EG
J Mol Cell Cardiol; 1999 Sep; 31(9):1725-37. PubMed ID: 10471356
[TBL] [Abstract][Full Text] [Related]
20. Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart.
Harrer JM; Haghighi K; Kim HW; Ferguson DG; Kranias EG
Am J Physiol; 1997 Jan; 272(1 Pt 2):H57-66. PubMed ID: 9038922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
